ReviewVascular health and risk management2016

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab.

Tiffany Y Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.